• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

DPO:GR

8.561 EUR 0.224 2.69%

As of 02:08:27 ET on 07/23/2014.

Snapshot for Depomed Inc (DPO)

Open: 8.557 Day's Range: 8.557 - 8.561 Volume: 0
Previous Close: 8.337 52wk Range: 4.524 - 10.942 1-Yr Rtn: +88.40%

Stock Chart for DPO

No chart data available.
  • DPO:GR 8.557
  • 1D
  • 1M
  • 1Y
8.337
Interactive DPO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DPO

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 134.1091
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 0.0860
Est. PEG Ratio -
Market Cap (M EUR) 496.46
Shares Outstanding (M) 57.99
30 Day Average Volume 274
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DPO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DPO

DepoMed, Inc. develops new and proprietary oral drug delivery technologies. The Company has developed a system designed to be retained in the stomach for an extended period of time while it delivers the incorporated drug or drugs. DepoMed has also developed a system designed to reduce gastrointestinal irritation.

James A Schoeneck "Jim"President/CEOAugust J MorettiSenior VP/CFO/Investor Relations
Srinivas G RaoSenior VP/Chief Medical OfficerMatthew M GoslingSenior VP/General Counsel
More Company Profile & Key Executives for DPO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil